Cargando…
A Case for Antibodies as Mechanistic Correlates of Immunity in Tuberculosis
Tuberculosis infects one quarter of the world's population and is the leading cause of death by a single infectious agent, responsible for a reported 1.3 million deaths in 2017. While Mycobacterium tuberculosis is treatable with antibiotic therapy, the increased prevalence of drug resistance, c...
Autores principales: | Kawahara, Jeffrey Y., Irvine, Edward B., Alter, Galit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521799/ https://www.ncbi.nlm.nih.gov/pubmed/31143177 http://dx.doi.org/10.3389/fimmu.2019.00996 |
Ejemplares similares
-
Defining Discriminatory Antibody Fingerprints in Active and Latent Tuberculosis
por: Nziza, Nadege, et al.
Publicado: (2022) -
Understanding the role of antibody glycosylation through the lens of severe viral and bacterial diseases
por: Irvine, Edward B, et al.
Publicado: (2020) -
Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis
por: Grifoni, Alba, et al.
Publicado: (2023) -
Extra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine
por: Boudreau, Carolyn M., et al.
Publicado: (2019) -
Mucosal Therapy of Multi-Drug Resistant Tuberculosis With IgA and Interferon-γ
por: Tran, Andy C., et al.
Publicado: (2020)